Getting Ours? “Girlbossing” and the Ethics of Nurse Reimbursement Models

Getting Ours? “Girlbossing” and the Ethics of Nurse Reimbursement Models

Introduction: This article politicizes a reimbursement model proposed by some professional nursing associations that aim to better align the price of nursing labor (nurses’ pay) to the value of nursing and make nurses’ contributions more visible. Methods: Using the concept of “missing care,” the cri...

Full description

Saved in:

Bibliographic Details
Main Authors:	Danisha Jenkins, Jennifer Cohen, Rae Walker, Patrick McMurray, Jess Dillard Wright
Format:	Article
Language:	English
Published:	Mary Ann Liebert 2024-12-01
Series:	Health Equity
Subjects:	reimbursement capitalism nursing industrial complex nurse reimbursement
Online Access:	https://www.liebertpub.com/doi/10.1089/heq.2024.0059
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017-01-01)

What is the role of antineoplastic drug safety in reimbursement decision making?
by: A. S. Kolbin, et al.
Published: (2018-11-01)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023-12-01)

Delayed access to innovative medicines in Romania: a comprehensive analysis of the reimbursement processes (2015–2024)
by: Constantin Radu, et al.
Published: (2025-05-01)

THE PROCEDURE OF REIMBURSEMENT OF THE COSTS INCURRED IN A TRIAL, IN A SUBSEQUENT TRIAL
by: Georgiana COMAN
Published: (2022-06-01)

Trends in Medicare Utilization and Reimbursement for Traumatic Brain Injury: 2003–2021
by: Sean Inzerillo, et al.
Published: (2024-10-01)

Should annual cost of the drug inform reimbursement decisions? A perspective from China’s healthcare security system
by: Xiaochen Peng, et al.
Published: (2025-04-01)

Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis
by: Hajer Dahmani, et al.
Published: (2023-12-01)

Analysing criteria for price and reimbursement of orphan drugs in Spain
by: Xavier Badia, et al.
Published: (2019-07-01)

Health technology assessment and reimbursement of pharmaceuticals in Italy
by: F. V. Gorkavenko, et al.
Published: (2019-07-01)

Are payers treating orphan drugs differently?
by: Joshua P. Cohen, et al.
Published: (2014-01-01)

Costs analysis of radiotherapy for breast cancer in Indonesia: a comparison between reimbursement tariffs and actual costs
by: Fithria Dyah Ayu Suryanegara, et al.
Published: (2025-05-01)

Tool for assessment of attitudes for applying a new approach in the decision-making process for reimbursement list in Bosnia and Herzegovina
by: Sabina Becirovic, et al.
Published: (2024-12-01)

MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016
by: A. S. Kolbin, et al.
Published: (2016-04-01)

Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience
by: Chakrapani Balijepalli, et al.
Published: (2025-04-01)

COVID-19’s effect on healthcare disparities: delivery, reimbursement, and premature mortality in residentially segregated populations
by: Kasabji Feras, et al.
Published: (2025-05-01)

Economic evaluation of biosimilars for reimbursement purposes – what, when, how?
by: Evelien Moorkens, et al.
Published: (2020-01-01)

When inequity impacts clinical care: an analysis of length of stay and reimbursement rates for medical stabilization for anorexia nervosa based on insurance coverage
by: Lance R. Nelson, et al.
Published: (2025-08-01)

Public perceptions of high-cost cancer drugs and the implications for reimbursement decisions
by: Youran Noh, et al.
Published: (2025-07-01)

Experience of Student Entrepreneurs in the Implementation of Businesses Financed with Non-Reimbursable Funds
by: Dragomir Camelia-Cristina, et al.
Published: (2024-12-01)

IMPLICATIONS OF NON-REIMBURSABLE FUNDS FOR ROMANIAN LOCAL BUDGETS
by: DAN CONSTANTIN DĂNULEŢIU, et al.
Published: (2015-10-01)

Setting the stage for risk-sharing agreements: International experiences and outcomes-based reimbursement
by: Joao L. Carapinha
Published: (2008-08-01)

Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region
by: Zoltán Kaló, et al.
Published: (2017-01-01)

The effect of health insurance reimbursement rates on middle-aged and elderly people’s hospital choices: evidence from China
by: Biao Li, et al.
Published: (2025-03-01)

Medicaid reimbursement for community violence intervention and prevention (CVI): a multi-state policy implementation case study
by: Sheetal Ranjan, et al.
Published: (2025-04-01)

A review of acknowledgement and payment preferences of contributors on a register of patient public involvement in brain injury research
by: James Piercy, et al.
Published: (2025-08-01)

The use of personal contact information for patient communication in ophthalmology
by: Kelsey M. Donovan, et al.
Published: (2025-07-01)

Pricing Zolgensma – the world’s most expensive drug
by: Mark Nuijten
Published: (2022-12-01)

The impact of the urban–rural residents’ medical insurance integration on rural residents’ out-of-pocket medical costs: based on the deductible, reimbursement rate, and ceiling line
by: Chen Liu, et al.
Published: (2025-04-01)

Introduction of medical products into healthcare practice and costs reimbursement: European experience
by: V. V. Omelyanovsky, et al.
Published: (2018-08-01)

Does the trans-provincial immediate reimbursement reduce health gap between urban and rural floating population? Evidence from China
by: Jun Tian, et al.
Published: (2025-05-01)

Microfinance et performance financière des microentreprises en Haïti
by: Hubermane Ciguino, et al.
Published: (2016-12-01)

APPROACHES TO REIMBURSEMENT FOR MEDICAL CARE WITHIN ANESTHESIOLOGY AND INTENSIVE CARE PROFILE DURING TRANSFER TO A NEW SYSTEM OF HEALTH CARE FUNDING
by: Yu. S. Polushin, et al.
Published: (2018-01-01)

Redefining reimbursement policies: A novel value framework for medical nutrition
by: Mohamed Nasser Farghaly, et al.
Published: (2025-06-01)

Understanding the financial aspects of digital pathology: A dynamic customizable return on investment calculator for informed decision-making
by: Orly Ardon, et al.
Published: (2024-12-01)

Opportunities and Challenges to Improve Postpartum Care: Payors’ and Purchasers’ Perspectives in California
by: Lindsay Parham, et al.
Published: (2025-01-01)

Pricing of orphan drugs in oncology and rare diseases
by: Mark Nuijten, et al.
Published: (2020-01-01)

Cost shifting or cost cutting by hospitals as a response to reimbursement reform? The case of diagnosis-related groups (DRG) scheme in China
by: Jiabi Wang, et al.
Published: (2025-08-01)

The health technology assessment system in Australia
by: V. V. Omelyanovskiy, et al.
Published: (2020-02-01)

Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers
by: Jong Kyu Park
Published: (2023-09-01)